These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7977268)

  • 1. Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient.
    Yamagishi S; Abe T; Sawada T
    Am J Gastroenterol; 1994 Dec; 89(12):2280. PubMed ID: 7977268
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic worsening of hepatitis C virus-related cryoglobulinemia subsequent to treatment with interferon alfa.
    Harlé JR; Disdier P; Pelletier J; Azulay JP; Perréard M; Weiller PJ; Jouglard J
    JAMA; 1995 Jul; 274(2):126. PubMed ID: 7595994
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C].
    Fernández I; Castellano G; Canga F; Colina F; García H; Fuertes A; Casis B; Martín A; Solís JA
    Gastroenterol Hepatol; 1995 Feb; 18(2):66-72. PubMed ID: 7621277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C.
    Chedin P; Cahen-Varsaux J; Boyer N
    Ann Intern Med; 1996 Sep; 125(6):521. PubMed ID: 8779481
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertriglyceridemia induced by interferon].
    Iborra C; Martinet C; Prigent F
    Ann Dermatol Venereol; 1996; 123(10):677. PubMed ID: 9615133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon therapy of chronic hepatitis C in hemophilia].
    Frickhofen N; Ellbrück D; Seifried E
    Dtsch Med Wochenschr; 1995 Feb; 120(5):157. PubMed ID: 7843037
    [No Abstract]   [Full Text] [Related]  

  • 8. Onset of diabetes with high titer anti-GAD antibody after IFN therapy for chronic hepatitis.
    Shiba T; Morino Y; Tagawa K; Fujino H; Unuma T
    Diabetes Res Clin Pract; 1995 Dec; 30(3):237-41. PubMed ID: 8861464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe hypertriglyceridemia during the course of treatment with interferon-alpha in a patient with chronic hepatitis C].
    Bory E; García Rico A; Pedro-Botet J; Sola R
    Gastroenterol Hepatol; 1996 Dec; 19(10):542. PubMed ID: 9044758
    [No Abstract]   [Full Text] [Related]  

  • 10. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertriglyceridemia following treatment with interferon alpha in essential thrombocythemia].
    De Salvo L; Plumacher Z; Gómez O; Weir-Medina J; Paz L; Salas D
    Invest Clin; 1996 Sep; 37(3):177-81. PubMed ID: 8983355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia during long-term interferon-alpha therapy in a series of hematologic patients.
    Sgarabotto D; Vianello F; Stefani PM; Scano F; Sartori R; Caenazzo A; Girolami A
    J Interferon Cytokine Res; 1997 May; 17(5):241-4. PubMed ID: 9181461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis C with alpha-interferon.
    Marcellin P
    Eur J Med; 1992; 1(4):194-5. PubMed ID: 1341443
    [No Abstract]   [Full Text] [Related]  

  • 14. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C.
    Barreca T; Corsini G; Franceschini R; Gambini C; Garibaldi A; Rolandi E
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):367-8. PubMed ID: 7600144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.
    Fabris P; Betterle C; Floreani A; Greggio NA; de Lazzari F; Naccarato R; Chiaramonte M
    Lancet; 1992 Aug; 340(8818):548. PubMed ID: 1354296
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM).
    Wonke B; Donohue SM; Hoffbrand AV; Scheuer PJ; Brown D; Dusheiko G
    Bone Marrow Transplant; 1993; 12 Suppl 1():24-5. PubMed ID: 8397033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
    Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
    Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. A case report.
    Berruti A; Gorzegno G; Vitetta G; Tampellini M; Dogliotti L
    Tumori; 1992 Oct; 78(5):353-5. PubMed ID: 1494811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertriglyceridemia caused by interferon-alpha].
    Jaubert D; Hadjali Y; de Jaureguiberry JP
    Presse Med; 1996 May; 25(17):820. PubMed ID: 8762285
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute axonal polyneuropathy during interferon alpha-2A therapy for chronic hepatitis type C.
    Negoro K; Fukusako T; Morimatsu M; Liao CM
    Muscle Nerve; 1994 Nov; 17(11):1351-2. PubMed ID: 7935561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.